NovaBay and Eyenovia Begin Co-Promotion of Eyecare Products to Ophthalmic Surgery Centers
Portfolio Pulse from Benzinga Newsdesk
NovaBay Pharmaceuticals and Eyenovia have started co-promoting eyecare products to ophthalmic surgery centers. Eyenovia's salesforce will promote NovaBay's Avenova and its own MydCombi, while NovaBay prepares for Eyenovia's Clobetasol launch in August 2024.
July 01, 2024 | 10:55 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eyenovia is leveraging its salesforce to promote NovaBay's Avenova and its own MydCombi, potentially increasing its sales and market presence. The upcoming launch of Clobetasol in August 2024 could further enhance its product portfolio.
By promoting both NovaBay's and its own products, Eyenovia can increase its market presence and sales. The future launch of Clobetasol adds a promising product to its portfolio, indicating potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
NovaBay Pharmaceuticals has started co-promoting its Avenova product with Eyenovia's salesforce, potentially increasing its market reach and sales. Additionally, NovaBay is preparing for the launch of Eyenovia's Clobetasol in August 2024.
The co-promotion agreement with Eyenovia allows NovaBay to leverage Eyenovia's salesforce, potentially boosting sales of Avenova. The preparation for Clobetasol's launch indicates future growth opportunities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100